Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 21, 2011

View Archived Issues

Phase II trial investigates SPD-503 in new indication

Genmab achieves milestone in collaboration with Lundbeck

Putative biomarker in non-cystic fibrosis bronchiectasis identified

Scientists at AstraZeneca present new therapy for AML

Malaria vaccine is safe and immunogenic in phase Ib study

Dual dopamine D2 receptor/NET inhibitors identified by Astellas Pharma

Novel glucocorticoid receptor agonist shows anti-inflammatory activity

New dipeptidyl peptidase 4 inhibitors patented by Chinese company

Novel p140-TrkA inhibitors prepared by Array BioPharma

Scientists at Mitsubishi Tanabe Pharma disclose new GPR119 receptor agonists

Abilify approved in Canada for use in new patient population

Dainippon Sumitomo Pharma presents novel amide derivatives

Merck & Co. synthesizes new PRCP inhibitors

Merck & Co. and Roche begin clinical collaboration for HCV infection

Phase II AX-200 study does not meet endpoints

Galapagos announces proof-of-mechanism milestone in alliance with GSK

Phase III study begins for ALKS-9070

New fenofibrate products launched in Japan for hyperlipidemia

Pharmasset to amend design of phase IIb PSI-938 trial

FDA approves Advate for new indication

CHMP issues recommendation on marketing authorization Esmya

Roche's Zelboraf receives CHMP opinion

ISTA Pharmaceuticals declines Valeant's acquisition offer

LabCorp acquires Orchid Cellmark

Zalicus begins phase I Z-944 study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...